๐๐๐๐๐ฅ๐ฌ๐๐ฅ๐๐ฆ ๐๐๐ง ๐๐๐๐ฎ๐
10 Nov,
7 tweets, 13 min read
๐ป๐ปLive in a few minutes โ๏ธ
#ClinicalTrialsMasterclass
๐ซDesigning trials in antiplatelet therapy, with @Drroxmehran @DjawidHashemi @aayshacader
๐
@KardiologieHH @ANazmiCalik @mirvatalasnag @Hragy @mmamas1973 @vass_vassiliou #CardioTwitter #DAPT
#ClinicalTrialsMasterclass
๐ซDesigning trials in antiplatelet therapy, with @Drroxmehran @DjawidHashemi @aayshacader
๐
@KardiologieHH @ANazmiCalik @mirvatalasnag @Hragy @mmamas1973 @vass_vassiliou #CardioTwitter #DAPT
https://twitter.com/kardiologiehh/status/1457343596642902016
Evolving duration of antiplatelet therapy #DAPT โคต๏ธ
๐ป1995 to 2020 ๐ป
@Drroxmehran #CardioTwitter
๐ป1995 to 2020 ๐ป
@Drroxmehran #CardioTwitter
Antiplatelet therapy: what can be tested โ๏ธ@Drroxmehran โคต๏ธ
@DjawidHashemi @aayshacader @KardiologieHH @mirvatalasnag @ANazmiCalik #CardioTwitter
@DjawidHashemi @aayshacader @KardiologieHH @mirvatalasnag @ANazmiCalik #CardioTwitter
@Drroxmehran explained possible differences between investigator-initiated trials and industry-sponsored trials. #CardioTwitter #DAPT โคต๏ธ
๐ซ๐ฉธComparison of the #TWILIGHT Trial with other #RCT on P2Y12 monotherapy, by @Drroxmehran #CardioTwitter โคต๏ธโคต๏ธ
@aayshacader @DjawidHashemi @KardiologieHH @mirvatalasnag @Hragy @SABOURETCardio @mmamas1973 @ANazmiCalik @CMichaelGibson
@aayshacader @DjawidHashemi @KardiologieHH @mirvatalasnag @Hragy @SABOURETCardio @mmamas1973 @ANazmiCalik @CMichaelGibson
๐ซHow to achieve โdouble-blindingโ in #antiplatelet therapy #trialsโ๏ธ
The need for๐ฅFirewalls๐ฅ๐
โคต๏ธ Great slide by @Drroxmehran about double-blind in the #TWILIGHT Trial #CardioTwitter
@mmamas1973 @DrPascalMeier @mirvatalasnag @KardiologieHH @DjawidHashemi @aayshacader
The need for๐ฅFirewalls๐ฅ๐
โคต๏ธ Great slide by @Drroxmehran about double-blind in the #TWILIGHT Trial #CardioTwitter
@mmamas1973 @DrPascalMeier @mirvatalasnag @KardiologieHH @DjawidHashemi @aayshacader
โข โข โข
Missing some Tweet in this thread? You can try to
force a refresh
ใ
